U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of The Impact of Globalization on Infectious Disease Emergence and Control

The Impact of Globalization on Infectious Disease Emergence and Control

Exploring the Consequences and Opportunities

Workshop Summary

; Editors: Stacey Knobler, Adel Mahmoud, Stanley Lemon, and Leslie Pray.

Washington (DC): National Academies Press (US); .
ISBN-10: 0-309-10098-4

Excerpt

This summary is organized as a topic-by-topic description of the presentations and discussions from the workshop. The purpose is to present lessons from relevant experience, delineate a range of pivotal issues and their respective problems, and put forth some potential responses as described by the workshop participants. The Summary and Assessment discusses the core messages that emerged from the working group discussions. Chapter 1 summarizes the presentations and discussions related to the increasing cross-border and cross-continental movements of people, products, pathogens, and power, and how these affect the emergence and spread of infectious diseases. Chapter 2 provides a summary of the presentations and discussions that revolved around the changing global landscape and how this could exacerbate the emergence and global spread of infectious diseases. Chapter 3 focuses on the opportunities and obstacles surrounding the global application of knowledge, tools, and technology that result from increasing globalization. Chapter 4 summarizes the means by which sovereign states and nations must adopt a global public health mind-set and develop a new organizational framework to maximize the opportunities and overcome the challenges created by globalization and build the necessary capacity to respond effectively to emerging infectious disease threats.

Contents

Support for this project was provided by the U.S. Department of Health and Human Services’ National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration; U.S. Agency for International Development; U.S. Department of Defense; U.S. Department of State; U.S. Department of Veterans Affairs; U.S. Department of Agriculture; American Society for Microbiology; Burroughs Wellcome Fund; Pfizer; GlaxoSmithKline; and the Merck Company Foundation. The views presented in this report are those of the editors and attributed authors and are not necessarily those of the funding agencies.

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.

Copyright © 2006, National Academy of Sciences.
Bookshelf ID: NBK56589PMID: 21850784DOI: 10.17226/11588

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (2.4M)

Related information

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...